In particular, higher ACE2 levels are present in patients who developed cutaneous symptoms in contrast to those with pneumonia or other respiratory involvement and in general, we observed lower, although only marginally significant, ACE2 levels in more severe patients. The gene discussed is ACE2; the disease is susceptibility to pneumonia measurement.